Bacterial infection-mediated anticancer activity (BIMAc)-Revisiting the molecular mechanisms

Journal of Medical Hypotheses and Ideas

Volumn 6, Issue 1, 2012, Pages 19-22

  Ramasamy, Soundhar ^a   Nattarayan, Vasugi ^a   Jayaraj, Gopal Gunanathan ^a   Arulanandh, Mary Diana ^a   Jaiswal, Alok ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Anticancer; Cancer; Centrosome; Cyclomodulins; Pathogen

Indexed keywords

BACTERIAL PROTEIN; CYCLOMODULIN; INTEGRIN LINKED KINASE; PROTEIN OSPE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION MEDIATED ANTINEOPLASTIC ACTIVITY; CANCER CELL; CELL MEMBRANE; CELL MIGRATION; CELL SUBPOPULATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CENTROSOME; EPITHELIUM CELL; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTESTINE EPITHELIUM; METASTASIS INHIBITION; MICROBIAL ACTIVITY; MITOSIS; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SHIGELLA FLEXNERI; SHIGELLOSIS; SPINDLE CELL;

EID: 84872039530     PISSN: 22517294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhi.2012.03.009     Document Type: Article

References (25)

1. McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 2006;26: 154-8.
2. Patyar S, Joshi R, Byrav DS, Prakash A, Medhi B, Das BK. Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci 2010;17: 21.
3. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci USA 2001;98: 15155-60.
4. Van Mellaert L, Barbé S, Anné J. Clostridium spores as antitumour agents. Trends Microbiol 2006;14: 190-6.
5. Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 2007;104: 10170-4.
6. Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005;102: 755-60.
7. Low KB, Ittensohn M, Luo X, Zheng LM, King I, Pawelek JM, Bermudes D. Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans. Methods Mol Med 2004;90: 47-60.
8. Galmbacher K, Heisig M, Hotz C, Wischhusen J, Galmiche A, Bergmann B, Gentschev I, Goebel W, Rapp UR, Fensterle J. Shigella mediated depletion ofmacrophages in a murine breast cancer model is associated with tumor regression. PLoS ONE 2010;5: e9572.
9. Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science 1995;270: 299-302.
10. Pawelek JM, Low KB, Bermudes D. Bacteria as tumourtargeting vectors. Lancet Oncol 2003;4: 548-56.
11. Kim M, Ogawa M, Fujita Y, Yoshikawa Y, Nagai T, Koyama T, Nagai S, Lange A, Fassler R, Sasakawa C. Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 2009;459: 578-82.
12. Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, Muller D, Kirikae T, Jackson PK, Kotani S, Sasakawa C. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell 2007;130: 611-23.
13. Nougayréde JP, Taieb F, De Rycke J, Oswald E. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol 2005;13: 103-10.
14. Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C, Grencis RK. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005;308: 1463-5.
15. Nigg EA. Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 2006;119: 2717-23.
16. Basto R, Brunk K, Vinadogrova T, Peel N, Franz A, Khodjakov A, Raff JW. Centrosomes amplification can initiate tumorigenesis in flies. Cell 2008;133: 1032-42.
17. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. Centrosomes amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci USA 2002;99: 1978-83.
18. Brinkley BR. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 2001;11: 18-21.
19. Fielding AB, Lim S, Montgomery K, Dobreva I, Dedhar S. A critical role of integrin linked ch-TOG and TACC3 in centrosome clustering in cancer cells. Oncogene 2011;30: 521-34.
20. Okuda J, Kurazono H, Takeda Y. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog 1995;18: 167-72.
21. Elwell C, Chao K, Patel K, Dreyfus L. Escherichia coli CdtB mediates Cytolethal distending toxin cell cycle arrest. Infect Immun 2001;69: 3418-22.
22. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, Pellman D. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 2008;22: 2189-203.
23. De Rycke J, Oswald E. Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol Lett 2001;203: 141-8.
24. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins Jr MJ, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, Tully JG, Russell RJ, Benvensite RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, Rice JM. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994;86: 1222-7.
25. Tamaki T, Naomoto Y, Kimura S, Kawashima R, Shirakawa Y, Shigemitus K, Yamatsuji T, Haisa M, Gunduz M, Tanaka N. Apoptosis in normal tissues induced by anticancer drugs. J Int Med Res 2003;31: 6-16.